Literature DB >> 34113162

The Value of Relative Size in the Ultrasound Diagnosis of Follicular Thyroid Neoplasm.

Sufang Zhang1, Liyan Huang1, Qingshan Huang2, Weili Wei1, Lijun Xie1, Jinshu Zeng1, Qiuyang Gu1, Ling Chen1, Shuqiang Chen1.   

Abstract

PURPOSE: Ultrasonography as the first choice for thyroid nodules is still difficult to distinguish between solid follicular thyroid neoplasm (FTN) and solid nodular goiter (NG). We tried to investigate the value of relative size (M/S, M: the maximum diameter of target nodule, S: the maximum diameter of the largest of the remaining nodules) that may help to differentiate FTN from NG.
METHODS: T test and chi-square test were used to retrospectively analyze the differences of the clinical and ultrasonographic characteristics between FTN and NG in 422 cases in our hospital. T test was used to analyze the difference of M/S value in the two kinds of nodules. ROC was used to evaluate the accuracy of M/S value in distinguishing the two.
RESULTS: There were statistically significant differences in age, echogenicity, calcification, peripheral halo and blood supply between the two. The M/S value is not only significantly different in the two kinds of nodules but also can be used as a quantitative indicator to guide ultrasound diagnosis. ROC analysis showed that the cutoff point and AUC of M/S value were 1.94 and 0.709, respectively.
CONCLUSION: In the ultrasound diagnosis of multiple thyroid nodules, the M/S value can better distinguish FTN and NG. We need to be aware of FTN when the M/S value of the nodule is greater than 2.
© 2021 Zhang et al.

Entities:  

Keywords:  follicular thyroid neoplasm; nodular goiter; size; ultrasonography

Year:  2021        PMID: 34113162      PMCID: PMC8184232          DOI: 10.2147/IJGM.S313468

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


Introduction

Follicular thyroid neoplasm (FTN) mainly included follicular adenoma (FA), follicular thyroid carcinoma (FTC) and their subtypes. It is one of the special pathological types in thyroid tumors. Among them, widely invasive FTC is considered a more aggressive disease for its distant metastasis through hematogenous dissemination, which leads to a poorer prognosis. Even preoperative fine needle aspiration (FNA) is also difficult to distinguish FTC from FA, so early detection of FTN is the most important thing to improve the prognosis.1–3 Compared with papillary thyroid carcinoma (PTC), FTC only has some descriptive features, such as be larger, with rich blood supply, and with a peripheral halo of uneven thickness, etc, more often lack the suspicious ultrasound features which characterize PTC.4,5 Single follicular carcinoma is easy to arouse our vigilance, but still a large number of FTC often coexist with benign nodules such as nodular goiter (NG) and lead to misdiagnosis. Since FTN is usually large, it should be prominent in the background of NG. Based on this, we attempted to explore the value of M/S value in ultrasonic diagnosis between FTN and NG.

Materials and Methods

This study was approved by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University ([2015] 084-1).

Patients and Data Collection

This retrospective cohort study included patients who were diagnosed as FTC, FA or nodular goiter after thyroidectomy from January 2012 to May 2020 at the First Affiliated Hospital of Fujian Medical University. A total of 422 nodules in 422 patients in our hospital were selected as the target nodules. Inclusion criteria for nodules: 1) Multiple nodules were included, with at least one nodule on both sides, and the number of nodules is no less than 3; 2) The ultrasonographic data of thyroid nodules was complete and clear, the location and size of the nodules corresponded to the pathological findings. Exclusion criteria: 1) The nodules were treated with drugs; 2) The nodules were poorly defined boundaries due to diffuse lesions such as Hashimoto’s thyroiditis, hyperthyroidism, and subacute thyroiditis.

Ultrasound Analysis

The preoperative ultrasonography was performed with a GE Logiq E9 or Toshiba Aplio 500 with a 10–14 MHz linear array probe. The number of the thyroid nodules, location, size, echogenicity, calcification, peripheral halo and blood supply were evaluated by ultrasonography. The M/S value (M: the maximum diameter of target nodule, S: the maximum diameter of the largest of the remaining nodules) was recorded (Figure 1). Each ultrasonography was evaluated by physicians with no less than 5 years of experience, and at least two physicians participated in each evaluation.
Figure 1

(A) The measurement method of M/S value. (B) Nodules in the figure were all NG. (C) The larger nodule in the figure was FTC.

(A) The measurement method of M/S value. (B) Nodules in the figure were all NG. (C) The larger nodule in the figure was FTC.

Statistical Analysis

SPSS22 was used for statistical analysis. T test and chi-square test were used to retrospectively analyze the differences of the clinical and ultrasonographic characteristics between FTN and NG. T test was used to analyze the difference of M/S value in the two kinds of nodules. ROC was used to evaluate the accuracy of M/S value in distinguishing the two. All the p-values were two-sided, and the significance level was set at 0.05.

Results

Clinical and Ultrasonic Features of FTN and NG

A total of 422 target nodules diagnosed as FTN or NG in our hospital were included in this study. We summarized the distribution of clinical and ultrasonic features in these patients (Figure 2). These characteristics include the patient’s gender, age, location of the nodule, echogenicity, calcification, peripheral halo, blood supply and size. These features show different distribution trends in FTN and NG. We further compared the differences in these clinical and ultrasonic features between FTN and NG (Table 1). The results showed that there were statistically significant differences between FTN and NG in patients’ age, echogenicity, calcification, peripheral halo, blood supply and size. FTN was more likely to be larger than NG, and often had calcification, peripheral halo and rich blood supply.
Figure 2

The clinical and ultrasonographic characteristics of FTN and NG.

Table 1

Differential Analysis of Clinical and Ultrasonographic Features Between FTN and NG

VariableNG (n=147)FTN (n=275)t/χ2P
Age (mean, year)50.47647.5642.2140.027
Gender
 Female1112040.0890.765
 Male3671
Location
 Left721270.3010.583
 Right75148
Echogenicity
 Hypoechoic671076.2360.044
 Isoechoic75141
 Hyperechoic527
Calcification
 None1382357.167 a0.019 a
 Macro935
 Micro05
Peripheral halo
 Existing3620191.9040.000
 Absent11174
Blood supply
 Scarce1006086.8950.000
 Rich47215
 Size (mean, cm)2.3243.5747.2360.000

Note: aFisher’s exact test.

Abbreviations: NG, nodular goiter; FTN, follicular thyroid neoplasm.

Differential Analysis of Clinical and Ultrasonographic Features Between FTN and NG Note: aFisher’s exact test. Abbreviations: NG, nodular goiter; FTN, follicular thyroid neoplasm. The clinical and ultrasonographic characteristics of FTN and NG. FTN can be further subdivided into FTC and FA, so we further analyzed the differences in clinical and ultrasonic characteristics between FTC and FA (Table 2). The results showed that there were statistically significant differences in echogenicity, calcification, blood supply and size between FTC and FA.
Table 2

Differential Analysis of Clinical and Ultrasonographic Features Between FTC and FA

VariableFTC (n=113)FA (n=162)t/χ2P
Age (mean, year)48.48746.9200.9480.344
Gender
 Female791251.8260.177
 Male3437
Location
 Left51760.0850.771
 Right6286
Echogenicity
 Hypoechoic654231.3060.000
 Isoechoic36105
 Hyperechoic1215
Calcification
 None881479.262 a0.006 a
 Macro2114
 Micro41
Peripheral halo
 Existing821190.0270.870
 Absent3143
Blood supply
 Scarce85224.4280.000
 Rich105110
 Size (mean, cm)3.9813.2913.2980.001

Note: aFisher’s exact test.

Abbreviations: FTC, follicular thyroid carcinoma; FA, follicular adenoma.

Differential Analysis of Clinical and Ultrasonographic Features Between FTC and FA Note: aFisher’s exact test. Abbreviations: FTC, follicular thyroid carcinoma; FA, follicular adenoma.

Differential Analysis of M/S Value Between FTN and NG

Through the observation of 422 target nodules, we found that the distribution of M/S values in FTN and NG showed different trends (Figure 2). Therefore, we further analyzed the difference of M/S values between FTN and NG. Our results showed that the M/S values of FTN were higher than that of NG (Figure 3A, Table 3), and the difference was statistically significant. FTN can be further divided into FTC and FA, so we analyzed it by stratification. However, our results showed that there was no significant difference in M/S value between FTCand FA (Figure 3B, Table 3). Therefore, we speculated that M/S value may have a certain potential value in ultrasonic diagnosis of FTN and NG.
Figure 3

(A) Difference of M/S values in FTN and nodular goiter. (B) Difference of M/S values in FTC and FA.

Table 3

Differential Analysis of M/S Values Between FTN (Including FTC and FA) and NG

VariableNG (n=147)FTN (n=275)t2P2
FTC (n=113)FA (n=162)t1P1
M/S (mean)2.8734.8105.1880.6590.5104.7460.000

Notes: t1 and P1 are the statistical values of FTC and FA. t2 and P2 are the statistical values of FTN (Including FTC and FA) and NG.

Abbreviations: FA, follicular adenoma; FTN, follicular thyroid neoplasm; FTC, follicular thyroid carcinoma; NG, nodular goiter.

Differential Analysis of M/S Values Between FTN (Including FTC and FA) and NG Notes: t1 and P1 are the statistical values of FTC and FA. t2 and P2 are the statistical values of FTN (Including FTC and FA) and NG. Abbreviations: FA, follicular adenoma; FTN, follicular thyroid neoplasm; FTC, follicular thyroid carcinoma; NG, nodular goiter. (A) Difference of M/S values in FTN and nodular goiter. (B) Difference of M/S values in FTC and FA.

The Predictive Value of M/S Values of FTN and NG in Ultrasonic Diagnosis and the Distribution of Them with M/S Values

In order to evaluate the potential value of M/S value in ultrasonic diagnosis of FTN and NG, we drew the ROC based on the distribution of M/S values in FTN and NG (Figure 4A). The optimal cutoff value was 1.94, the sensitivity was 0.756, the specificity was 0.612, and the AUC was 0.709. Therefore, the optimal cutoff value (1.94) could better distinguish FTN from NG.
Figure 4

(A) The predictive value of M/S value in thyroid ultrasonography. (B) Corresponding relationship between two kinds of thyroid nodules with M/S value. (C) The distribution of FTN and NG with M/S values in 422 thyroid target nodules.

(A) The predictive value of M/S value in thyroid ultrasonography. (B) Corresponding relationship between two kinds of thyroid nodules with M/S value. (C) The distribution of FTN and NG with M/S values in 422 thyroid target nodules. Here, the M/S values of FTN and NG were divided into High group (greater than 1.94) and Low group (less than 1.94) based on the optimal cutoff value of M/S (1.94). We found that FTN was mostly distributed in the High group, while NG was mostly distributed in the Low group (Figure 4B). Notably, we found that with the increase of M/S value, the probability of thyroid nodules being FTN was higher. On the contrary, with the decrease of M/S value, the possibility of thyroid nodules being NG was higher (Figure 4C). Therefore, the optimal cutoff value (1.94) could better distinguish FTN from NG.

Discussion

FTC originates from the follicular epithelium of thyroid. Though with rare lymph node metastasis,6 FTC has a high risk of distant metastasis. The risk of distant metastasis in FTC ranges from a low of 3.0% to almost 30%.7 Distant metastasis is closely associated with increased vascular invasion, which also occurred in some patients with capsular invasion alone, leading to a worse prognosis.8–11 It is difficult to distinguish between FTC and FA before surgery, and the reliability in detecting FTN by several current mainstream ultrasound risk stratification systems were also considered to be in need of further improvement.12,13 The risk of malignancy with a FNAB reading of FTN (Bethesda IV) is 10–40% and 6–28% with AUS/FLUS (Bethesda III).14,15 The distinction between benign and malignant FTN still requires complete surgical pathology. FTN lacks the suspicious ultrasound features which characterize PTC, and is very similar to the common non-neoplastic adenomatous hyperplastic nodule. Therefore, it is challenging and important to screen out FTN among the numerous thyroid nodules. Ultrasound is the most convenient and effective tool for diagnosing thyroid nodules currently. The FTN and the NG groups showed significant differences in echogenicity, calcification, etc. But those differences were descriptive characteristics, which were not enough to make a diagnosis. Moreover, signs such as calcification as a sonographic indicator of FTN remain under debate.5 Some studies have reported that nodules with irregular margin and unclear border tend to be malignant,16,17 but these descriptive features were subject to a certain degree. In our study, the more prominent differences between the FTN group and the NG group were the presence of peripheral halo and the blood supply status of the nodules. Most studies also supported that a peripheral halo of uneven thickness and abundant blood supply were better indicators for distinguishing FTN from NG.18 In NG, the formation and growth of nodules are mainly caused by the heterogeneity among follicular cells, which show different growth potential when stimulated by TSH. So the natural history of these benign nodules resulted in gradually increasing size. FTN is a kind of neoplasm with the ability of colony-formation, accompanied by molecular genetic changes. Oncogenic changes in FTC are primarily RAS point mutations and PAX8/PPARγ rearrangements.7,19,20 It is precisely because of the different growth mechanisms leading to the fact that FTN grows faster than NG, and makes FTN appeared more prominent and eye-catching in the background of NG. Based on this principle, we had observed that the most intuitive expression was that FTN tended to appear as “outstanding” nodules, that was, the nodules were significantly larger than the surrounding nodules. In our study, the FTN and the NG groups showed significant difference in M/S value, that was, the M/S values of FTN were higher than that of NG. The FTC and FA groups showed no significant difference in M/S value was considered as the similar pathogenesis of the two. According to the ROC we drew, the optimal cutoff value of M/S was 1.94, and the sensitivity and specificity of diagnosis at this time were 75.6% and 61.2%, respectively. The incidence of FTC is relatively lower than that of PTC, FA and minimally invasive FTC occupy the majority of FTN.21 To avoid overdiagnosis and overtreatment of thyroid nodules, we considered “the M/S value >2” to be more suitable, as the specificity can be appropriately increased to reduce overdiagnosis. In addition, the value of M/S >2 is simple and convenient for clinical application. Nodules which were predominantly cystic were excluded in our study. Both FTN and NG can have cystic change, which leads to nodules growth in a short time, rather than substantial growth. The M/S value cannot be generalized, of course. For example, if the nodules are spongy or with multiple separated cystic regions accompanied by spots with comet tail sign inside,22 no matter how high the M/S value is, NG is the first consideration. In the same way, even if the nodule does not appear “outstanding”, it is accompanied by some typical features such as a peripheral halo with uneven thickness, FTN is the first consideration.

Conclusion

During the ultrasonography of thyroid nodules, if one of the multiple nodules is significantly larger than other surrounding nodules and with rich blood supply, especially when the M/S is higher than 2, we should beware of the possibility of FTN.
  22 in total

1.  Ultrasonographic features for differentiating follicular thyroid carcinoma and follicular adenoma.

Authors:  Ting-Chun Kuo; Ming-Hsun Wu; Kuen-Yuan Chen; Min-Shu Hsieh; Argon Chen; Chiung-Nien Chen
Journal:  Asian J Surg       Date:  2019-06-08       Impact factor: 2.767

2.  Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer.

Authors:  Mona M Sabra; Ronald Ghossein; R Michael Tuttle
Journal:  Thyroid       Date:  2016-02-12       Impact factor: 6.568

Review 3.  Gene Fusions in Thyroid Cancer.

Authors:  Valentina D Yakushina; Larisa V Lerner; Alexander V Lavrov
Journal:  Thyroid       Date:  2018-02       Impact factor: 6.568

Review 4.  Molecular diagnostics of thyroid tumors.

Authors:  Yuri E Nikiforov
Journal:  Arch Pathol Lab Med       Date:  2011-05       Impact factor: 5.534

5.  Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.

Authors:  M M Sabra; J M Dominguez; R K Grewal; S M Larson; R A Ghossein; R M Tuttle; J A Fagin
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

6.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; Marie R Griffin; John E Phay
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

Review 7.  Follicular thyroid cancer and Hürthle cell carcinoma: challenges in diagnosis, treatment, and clinical management.

Authors:  Giorgio Grani; Livia Lamartina; Cosimo Durante; Sebastiano Filetti; David S Cooper
Journal:  Lancet Diabetes Endocrinol       Date:  2017-11-05       Impact factor: 32.069

8.  Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma?

Authors:  Marco Castellana; Arnoldo Piccardo; Camilla Virili; Lorenzo Scappaticcio; Giorgio Grani; Cosimo Durante; Luca Giovanella; Pierpaolo Trimboli
Journal:  Cancer Cytopathol       Date:  2020-01-03       Impact factor: 5.284

9.  Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms.

Authors:  Andrej Vogrin; Hana Besic; Nikola Besic; Maja Marolt Music
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

10.  Evaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytology.

Authors:  Krzysztof Kaliszewski; Dorota Diakowska; Beata Wojtczak; Zdzisław Forkasiewicz
Journal:  Cancer Manag Res       Date:  2018-07-23       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.